ERYP

ERYTECH Pharma S.A. (ERYP) | Rumor.io

ERYTECH Pharma

ERYP

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about ERYP?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% +0

May 10

ERYTECH Pharma S.A. ($ERYP) has broken through the $0.95 resistance level and closed outside of its Bollinger Bands, indicating a potential acceleration to the upside in the coming days.
Short sale volume for $ERYP on May 9, 2023, was 52%, and the stock has seen a rapid price rise of 40% since the previous day's close, trading at $1.31.
$ERYP has a Quick Ratio of 3.65, indicating that the company is financially healthy, and the stock is showing decent relative strength.

Generated by AI

Sentiment

Of the messages about ERYP that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	—
Bearish	—	—	—	—

Bullish· Apr 25

*$ERYP has strong technical support at $1.72, with a buyer protecting it from short sellers.*
*$ERYP has a small float of 6 million shares, which could lead to significant price appreciation if the right volume is achieved.*
*$ERYP is in a favorable technical setup, with a strong chance of breaking through $2.50 and potentially reaching $3.00 or $4.00.*

Bearish· Apr 25

$ERYP is too extended and needs a gap fill down to 1.22 for its previous close.
ERYTECH Pharma S.A. is losing business and its growth is being minimized, which is a negative sign for the company.
The stock's short float is 6 million shares, making it a high-risk asset to short, but it could potentially surge to $5.00 or more in a short period.

Generated by AI

Topics

Of the messages about ERYP that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	—
Announcements	—	—	—	—
Controversies	—	—	—	—
Earnings	—	—	—	—
Macro	—	—	—	—
Technical Analysis	—	—	—	—

Announcements· May 9

ERYTECH Pharma S.A. provided a business and financial update for the first quarter of 2023, which included information on cash and cash equivalents of $33.7M at the end of March 2023.
The company intends to merge its operations with Pherecydes and relocate all teams to Erytech's premises in Lyon, with the transaction expected to close shortly after approval by shareholders.
Akkadian Partners declared crossing the 5% threshold of voting rights, holding 1,755,145 ERYTECH PHARMA shares, and indicated a commitment to increasing their stake up to 15% in the short term and approximately 25% in the medium term.

Technical Analysis· Jul 30

ERYTECH Pharma S.A. (ERYP) is trading around 8.25, with a potential breakout at 9.
The stock's VWAP is at 8.44, and its RSI is at 48, indicating no immediate concerns for a decline.
A reversal is expected soon, with the stock following the Dow's chart and nearing a potential breakout above 7.

Generated by AI

Community

Of the messages about ERYP, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	0%
Newcomers	—	—	—	100%

Also Discussed

Investors talking about ERYP also mention

#	Name	Attention
1	BeyondSpring Inc.BYSI	0%0
2	Innate Pharma S.A. Sponsored ADRIPHA	0%0
3	WHLM - Wilhelmina International, Inc.	——
4	ANGN - Angion Biomedica Corp.	——
5	NanoVibronix, Inc.NAOV	0%0
6	Virpax Pharmaceuticals Inc.VRPX	0%0
7	MediaCo Holding Inc. Class A Common StockMDIA	0%0
8	AlloVir, Inc.ALVR	0%0
9	PharmaCyte Biotech, Inc.PMCB	0%0
10	Zivo Bioscience Inc.ZIVO	0%0

ERYTECH Pharma S.A.

Location

Social

What share of all stock conversation is about ERYP?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% +0

May 10

ERYTECH Pharma S.A. ($ERYP) has broken through the $0.95 resistance level and closed outside of its Bollinger Bands, indicating a potential acceleration to the upside in the coming days.
Short sale volume for $ERYP on May 9, 2023, was 52%, and the stock has seen a rapid price rise of 40% since the previous day's close, trading at $1.31.
$ERYP has a Quick Ratio of 3.65, indicating that the company is financially healthy, and the stock is showing decent relative strength.

Generated by AI

Sentiment

Of the messages about ERYP that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	—
Bearish	—	—	—	—

Bullish· Apr 25

*$ERYP has strong technical support at $1.72, with a buyer protecting it from short sellers.*
*$ERYP has a small float of 6 million shares, which could lead to significant price appreciation if the right volume is achieved.*
*$ERYP is in a favorable technical setup, with a strong chance of breaking through $2.50 and potentially reaching $3.00 or $4.00.*

Bearish· Apr 25

$ERYP is too extended and needs a gap fill down to 1.22 for its previous close.
ERYTECH Pharma S.A. is losing business and its growth is being minimized, which is a negative sign for the company.
The stock's short float is 6 million shares, making it a high-risk asset to short, but it could potentially surge to $5.00 or more in a short period.

Generated by AI

Topics

Of the messages about ERYP that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	—
Announcements	—	—	—	—
Controversies	—	—	—	—
Earnings	—	—	—	—
Macro	—	—	—	—
Technical Analysis	—	—	—	—

Announcements· May 9

ERYTECH Pharma S.A. provided a business and financial update for the first quarter of 2023, which included information on cash and cash equivalents of $33.7M at the end of March 2023.
The company intends to merge its operations with Pherecydes and relocate all teams to Erytech's premises in Lyon, with the transaction expected to close shortly after approval by shareholders.
Akkadian Partners declared crossing the 5% threshold of voting rights, holding 1,755,145 ERYTECH PHARMA shares, and indicated a commitment to increasing their stake up to 15% in the short term and approximately 25% in the medium term.

Technical Analysis· Jul 30

ERYTECH Pharma S.A. (ERYP) is trading around 8.25, with a potential breakout at 9.
The stock's VWAP is at 8.44, and its RSI is at 48, indicating no immediate concerns for a decline.
A reversal is expected soon, with the stock following the Dow's chart and nearing a potential breakout above 7.

Generated by AI

Community

Of the messages about ERYP, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	0%
Newcomers	—	—	—	100%

ERYTECH Pharma

Social

May 10

Sentiment

Bullish· Apr 25

Bearish· Apr 25

Topics

Announcements· May 9

Technical Analysis· Jul 30

Community

Also Discussed

ERYTECH Pharma S.A.

Company Information

Location

Also Discussed

Social

May 10

Sentiment

Bullish· Apr 25

Bearish· Apr 25

Topics

Announcements· May 9

Technical Analysis· Jul 30

Community